News

The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

Atai Life Sciences Announces Results from Phase 2a Trial of PCN-101 (R-ketamine) for Treatment-Resistant Depression

Saturday, January 07, 2023

Atai Life Sciences a clinicalstage biopharmaceutical company focused on mental health announced that while PCN Rketamine demonstrated signals of efficacy across all timepoints out to two weeks

Helix and QIAGEN Form Exclusive Global Partnership to Develop and Commercialize Companion Diagnostics for Hereditary Diseases

Friday, January 06, 2023

Helix the leading population genomics and viral surveillance company in the nation announced today a global strategic partnership with QIAGEN NV the leading global

SciSparc Ltd. Announces Efficacy of Psychedelic-Based Obesity Treatment of Clearmind Medicine Inc. in Pre-Clinical Trial

Friday, January 06, 2023

The results are in connection with the provisional patent application for treating metabolic syndromes including obesity with Clearmind based on SciSparcs CannAmides active ingredient Palmitoylethanolamide and Clearminds MEAI submitted in September

Kane Biotech Announces First Distribution Agreement for its coactiv+™ Antimicrobial Hydrogel

Thursday, January 05, 2023

Kane Biotech Inc has announced a recent distribution agreement with Salud Pharma SA for the distribution of its coactiv Antimicrobial Hydrogel wound care and DermaKB scalp care products

Applied Therapeutics Announces Partnership with Advanz Pharma for Commercialization of AT-007 (Govorestat) in Europe

Thursday, January 05, 2023

Applied Therapeutics Inc a clinicalstage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need today

Biocytogen and Hansoh Pharma Announce an Antibody License Agreement

Wednesday, January 04, 2023

Biocytogen Pharmaceuticals Beijing Co Ltd a clinicalstage biotechnology company with a focus on the antibody discovery and development based on its proprietary

Procaps Group Announces Termination of Acquisition Agreement with Grupo Somar

Wednesday, January 04, 2023

Procaps Group SA a leading integrated LatAm healthcare and pharmaceutical conglomerate today announced the termination of its previouslyreported definitive agreement the SPA to acquire Grupo Somar from the sellers under the SPA As previously reported...

Israel-Based Clearmind Medicine Announces First Clinical Center to Join Its Clinical Trial for Alcohol Use Disorder

Thursday, December 29, 2022

Clearmind Medicine Inc a biotech company focused on discovery and development of novel psychedelicderived therapeutics to solve major undertreated health problems

BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China

Friday, December 23, 2022

BioNTech SE and Shanghai Fosun Pharmaceutical Group Co Ltd announced that the companies provided approximately doses of mRNAbased COVID vaccines which arrived on the Chinese Mainland on December The delivery contains both the companies Omicron BA...

OKYO Pharma Announces U.S. FDA Clearance of IND Application for OK-101 for the Treatment of Dry Eye Disease

Friday, December 23, 2022

OKYO Pharma Limited an ophthalmologyfocused biopharmaceutical company developing OK to treat dry eye disease DED to address the significant unmet need in this multibilliondollar market today announced that it has received clearance of its Investigati...